Target intelligence / Profile preview

Basic salivary proline-rich protein 1 (PRB1)

Target
PRB1
Molecular classification
Other (intrinsically unstructured protein), Secreted protein, Salivary protein, Proline-rich protein family
01

Overview

Basic salivary proline-rich protein 1 (PRB1) is a major component of salivary proline-rich proteins (PRPs) in humans. Encoded by the PRB1 gene, it belongs to a family of polymorphic, secreted, intrinsically unstructured proteins characterized by high proline content and repetitive sequence motifs. PRB1 is involved in the maintenance of oral health, contributing to the formation of the enamel pellicle, lubricating oral surfaces, binding plant polyphenols (tannins), and modulating microbial adhesion, thereby playing a protective role in the oral cavity. The PRB1 gene is clustered with other PRP genes on chromosome 12p13, which also encodes related proteins with similar structural and functional properties. PRB1 is not known to be a classical therapeutic target such as a receptor, transporter, or enzyme, and no drugs currently target it directly. However, PRB1 genetic variants have been studied for their polymorphisms and potential associations with oral or systemic diseases.

Other names
Proline rich protein BstNI subfamily 1Basic salivary proline-rich protein 1PRB1Proline-rich peptide II-2Basic peptide IB-6Peptide P-HSalivary proline-rich proteinPMPMFPMSPRB1MPRB1LParotid middle band proteinSalivary protein Pe
02

Mechanism of action

Not applicable; not a druggable or classical pharmacological target

03

Biological functions

Formation and maintenance of the enamel pellicle (protective oral environment)Lubrication of oral surfacesPrecipitation/binding of dietary tanninsModulation of bacterial adhesion to oral surfacesPolymorphic defense molecule in saliva
04

Disease associations

Possible association with Head and Neck CancerPossible association with Pelizaeus-Merzbacher DiseaseOther (supportive role in oral health, polymorphisms may influence disease susceptibility)
05

Safety considerations

None reported; not subject to notable safety issues in therapeutic or diagnostic use
06

Interacting drugs

None documented as interacting drugs; not a known direct therapeutic target for approved drugs
07

Biomarkers

None established; variants may technically serve as molecular markers for genetic polymorphism studies but not for therapeutic patient selection

Beyond the preview

Go deeper on Basic salivary proline-rich protein 1 (PRB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basic salivary proline-rich protein 1 (PRB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call